The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop
therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is …

Each B-cell receptor consists of a pair of heavy and light chains. High-throughput sequencing
can identify large numbers of heavy- and light-chain variable regions (V H and V L ) in a …

The molecular composition and binding epitopes of the immunoglobulin G (IgG) antibodies
that circulate in blood plasma after severe acute respiratory syndrome coronavirus 2 (SARS-…

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …

The low stability of natural proteins often limits their use in therapeutic, industrial, and
research applications. The scale and throughput of methods such as circular dichroism, …

Molecular understanding of serological immunity to influenza has been confounded by the
complexity of the polyclonal antibody response in humans. Here we used high-resolution …

The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
highlights the urgent need for assays that detect protective levels of neutralizing antibodies. We …

Most vaccines confer protection via the elicitation of serum antibodies, yet more than 100 y
after the discovery of antibodies, the molecular composition of the human serum antibody …

We have developed and validated a methodology for determining the antibody composition
of the polyclonal serum response after immunization. Pepsin-digested serum IgGs were …

Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that
detect levels of neutralizing antibodies that may be protective. We studied the relationship …